The University of Chicago Header Logo

Connection

Yusuke Nakamura to Immunohistochemistry

Back to Details
This is a "connection" page, showing publications Yusuke Nakamura has written about Immunohistochemistry.
Yusuke Nakamura
Connection Strength
1.005
Immunohistochemistry
  1. WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer. Sci Rep. 2017 01 19; 7:40664.
    View in: PubMed
    Score: 0.094
  2. Involvement of C12orf32 overexpression in breast carcinogenesis. Int J Oncol. 2010 Oct; 37(4):861-7.
    View in: PubMed
    Score: 0.061
  3. Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells. Oncol Rep. 2009 Feb; 21(2):305-12.
    View in: PubMed
    Score: 0.054
  4. Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene. 2005 Sep 15; 24(41):6201-12.
    View in: PubMed
    Score: 0.043
  5. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 2005 Jul 01; 65(13):5638-46.
    View in: PubMed
    Score: 0.042
  6. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET. Cancer Res. 2005 Jun 01; 65(11):4578-86.
    View in: PubMed
    Score: 0.042
  7. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res. 2005 Apr 15; 65(8):3092-9.
    View in: PubMed
    Score: 0.042
  8. Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet. 2004 Dec 15; 13(24):3029-43.
    View in: PubMed
    Score: 0.040
  9. Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet. 2003; 48(6):293-299.
    View in: PubMed
    Score: 0.036
  10. Clinicopathologic significance of protein lysine methyltransferases in cancer. Clin Epigenetics. 2020 10 13; 12(1):146.
    View in: PubMed
    Score: 0.031
  11. Critical role of lysine 134 methylation on histone H2AX for ?-H2AX production and DNA repair. Nat Commun. 2014 Dec 09; 5:5691.
    View in: PubMed
    Score: 0.020
  12. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas. Cancer Res. 2012 Nov 15; 72(22):5867-77.
    View in: PubMed
    Score: 0.017
  13. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis. Genes Chromosomes Cancer. 2013 Feb; 52(2):126-39.
    View in: PubMed
    Score: 0.017
  14. Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer. Jpn J Clin Oncol. 2012 Jul; 42(7):591-600.
    View in: PubMed
    Score: 0.017
  15. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis. Cancer Sci. 2012 Mar; 103(3):577-86.
    View in: PubMed
    Score: 0.017
  16. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nat Commun. 2012; 3:1072.
    View in: PubMed
    Score: 0.017
  17. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer. Clin Cancer Res. 2011 Dec 15; 17(24):7712-22.
    View in: PubMed
    Score: 0.016
  18. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia. 2011 Oct; 13(10):887-98.
    View in: PubMed
    Score: 0.016
  19. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer. 2011 Feb 01; 128(3):574-86.
    View in: PubMed
    Score: 0.016
  20. Association of EMCN with susceptibility to rheumatoid arthritis in a Japanese population. J Rheumatol. 2011 Feb; 38(2):221-8.
    View in: PubMed
    Score: 0.015
  21. Identification of SPARC as a candidate target antigen for immunotherapy of various cancers. Int J Cancer. 2010 Sep 01; 127(6):1393-403.
    View in: PubMed
    Score: 0.015
  22. Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis. Genes Chromosomes Cancer. 2010 Apr; 49(4):353-67.
    View in: PubMed
    Score: 0.015
  23. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 2009 Nov 15; 69(22):8752-60.
    View in: PubMed
    Score: 0.014
  24. Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer. Cancer Sci. 2009 Nov; 100(11):2109-14.
    View in: PubMed
    Score: 0.014
  25. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer. Cancer Sci. 2009 Aug; 100(8):1468-78.
    View in: PubMed
    Score: 0.014
  26. Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis. Cancer Sci. 2009 Aug; 100(8):1443-50.
    View in: PubMed
    Score: 0.014
  27. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity. Ann Nucl Med. 2009 Jul; 23(5):479-85.
    View in: PubMed
    Score: 0.014
  28. Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci. 2009 May; 100(5):914-9.
    View in: PubMed
    Score: 0.014
  29. Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors. Cancer Sci. 2009 Mar; 100(3):405-12.
    View in: PubMed
    Score: 0.013
  30. Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis. Cancer Sci. 2009 Mar; 100(3):457-64.
    View in: PubMed
    Score: 0.013
  31. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL. Int J Cancer. 2008 Dec 01; 123(11):2616-25.
    View in: PubMed
    Score: 0.013
  32. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure. J Urol. 2008 Aug; 180(2):481-5.
    View in: PubMed
    Score: 0.013
  33. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci. 2008 Feb; 99(2):432-40.
    View in: PubMed
    Score: 0.013
  34. Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell Microbiol. 2008 Apr; 10(4):908-20.
    View in: PubMed
    Score: 0.012
  35. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci. 2008 Jan; 99(1):62-70.
    View in: PubMed
    Score: 0.012
  36. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer. Cancer Sci. 2007 Dec; 98(12):1902-13.
    View in: PubMed
    Score: 0.012
  37. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res. 2006 Sep 15; 66(18):9186-95.
    View in: PubMed
    Score: 0.011
  38. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol. 2006 Aug; 29(2):381-6.
    View in: PubMed
    Score: 0.011
  39. Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses. Mol Ther. 2006 Oct; 14(4):599-606.
    View in: PubMed
    Score: 0.011
  40. Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression. Clin Cancer Res. 2006 May 01; 12(9):2767-73.
    View in: PubMed
    Score: 0.011
  41. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin Cancer Res. 2006 Jan 01; 12(1):70-6.
    View in: PubMed
    Score: 0.011
  42. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Int J Oncol. 2005 Dec; 27(6):1483-7.
    View in: PubMed
    Score: 0.011
  43. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology. 2005 Jun; 41(6):1339-48.
    View in: PubMed
    Score: 0.011
  44. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep. 2004 Aug; 12(2):275-80.
    View in: PubMed
    Score: 0.010
  45. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem. 2004 Feb 20; 279(8):6840-6.
    View in: PubMed
    Score: 0.009
  46. Cystatin 10, a novel chondrocyte-specific protein, may promote the last steps of the chondrocyte differentiation pathway. J Biol Chem. 2003 Nov 28; 278(48):48259-66.
    View in: PubMed
    Score: 0.009
  47. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun. 2003 Jun 20; 306(1):16-25.
    View in: PubMed
    Score: 0.009
  48. p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol. 2003 Mar; 5(3):216-23.
    View in: PubMed
    Score: 0.009
  49. Inhibition of experimental intimal thickening in mice lacking a novel G-protein-coupled receptor. Circulation. 2003 Jan 21; 107(2):313-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.